Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Pharmacophore

Quantum–Classical Drug Discovery after the Advantage Claim: Matching Computational Methods to Problems They Can Credibly Solve

David Thompson, Sarah Mitchell, Rachel Adams, James Brown

Published Jan 1, 2025• 0 citations
Publisher

Abstract

Quantum computing has become increasingly visible in pharmaceutical research, yet the evidentiary meaning of an “advantage” claim remains unsettled. Drug discovery contains heterogeneous scientific decisions, data structures, computational abstractions, validation standards, and translational consequences. Consequently, improvement in circuit execution, molecular-energy estimation, sampling, classification, or candidate generation cannot by itself establish pharmaceutical usefulness. This Origin

DOI
10.51847/d59nkxqobj

Related papers

After the Quantum Advantage Claim: Which Drug-Discovery Problems Are Actually Ready for Quantum Computation?

Lucas Meyer, Anna Schmid, Stefan Braun +1 more

Quantum computation is increasingly presented as a potential response to difficult molecular-simulation, optimization, and machine-learning problems in drug discovery. However, the existence of computationally demanding pharmaceutical tasks does not establish that quantum methods can solve them more accurately, efficiently, or usefully than contemporary classical approaches. This horizon-scanning review evaluates which problem classes currently justify bounded quantum research programs and which

Pharmacophore•Jan 1, 2026•0 citations

Quantum Computing in Drug Discovery: Revolutionizing Pharmaceutical Research

Anandhavalli Muniasamy

The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.

IGI Global eBooks•Jul 11, 2025•8 citations

Quantum Computing: Revolutionizing Drug Discovery and Battery Development

G. Deepalakshmi, S.K. Sunori, K.V. Padmavathi +3 more

Quantum computing promises to be a game changer for drug discovery and battery development as it will enable simulations of complex molecular and material systems not possible in classical regimes. Here, we introduce a hardware-aware, hybrid quantum-classical framework designed for practical pharmaceutical and energy problems. Extending state-of-the-art results from quantum machine learning, quantum-inspired optimization, and domain-specific datasets, the model improves both scalability and accuracy as well as interpretability. The proposed method is validated from real-drug and battery chemistry with advantages over the traditional method. This interdisciplinary breakthrough tackles major drawbacks of current quantum approaches and provides a realistic pathway towards industrial implementation in chemistry-led innovation.

CRC Press eBooks•Sep 7, 2026•0 citations

Accelerating Drug Discovery with Quantum Computing

V. Mahesh, Shimil Shijo

The evolution of molecular formulations into medications to treat or remedy diseases is the foundation of the pharmaceutical business. Therefore, it is crucial that the pharmaceutical industry devotes a full 15% of its sales to research and development, which accounts for more than 20% of all R&D expenditures across all productions in the global economy. The trial-and-error method is typically used to create drugs, which is not only expensive but also risky and difficult to complete. Drug companies may potentially save a huge money and time by using quantum computing to better understand drugs and their effects on people. By enabling businesses to undertake more drug discoveries and develop breakthrough medical treatments, these computer advancements have the potential to significantly boost efficiency and lead to a more productive pharmaceutical industry. Pharmaceutical research and development has recently embraced artificial intelligence (AI). The succeeding digital frontier in drug detection is quantum computing (QC).

Wiley eBooks•May 29, 2023•8 citations

Quantum Computing in Pharmaceutical Science

Bancha Yingngam

In the field of pharmaceutical science, there is an increasing demand for advanced computational techniques to enhance drug discovery and understand complex molecular interactions. Classical models, despite their strengths, often struggle with complex biological systems and accurate drug predictions. Quantum computing, using qubits that exist in multiple states, processes information at unparalleled speeds. This chapter sheds light on the principles of quantum computing, emphasizing algorithms specifically designed for pharmaceutical applications. These methods signal groundbreaking advancements in drug design, molecular simulation, and drug interaction predictions. Quantum computers have the potential to surpass classical computers in simulating intricate molecules, thus offering more precise drug side effect forecasts. While challenges such as noise and error rates remain, the continuous evolution of quantum technology holds significant potential for breakthroughs in drug discovery and development.

Advances in computer and electrical engineering book series•Jan 31, 2024•3 citations

Pharmaceutical Data Optimisation Using Quantum Machine Learning

J. N. Ekatpure, Pallavi Jadhav, Rupali Gavali +2 more

The pharmaceutical industry stands at the forefront of scientific innovation, aiming to develop novel drugs that address the world's most pressing health challenges. However, the process of drug discovery and development is wrought withchallenges, including the need for precision in molecular modelling, the efficientselection of promising drug candidates, and the rigorous evaluation of safety profiles. In response to these challenges, this research project explores the fusion ofquantum computing and machine learning to revolutionize pharmaceutical dataanalysis. Quantum computing offers an unprecedented opportunity to simulatemolecular structures and properties with unparalleled accuracy. In tandem withquantum machine learning algorithms, this research harnesses the power of quantum computational supremacy to unlock hidden insights within pharmaceuticaldatasets. By leveraging the capabilities of quantum computing for molecular simulation and the data analysis prowess of quantum machine learning, this studyseeks to expedite drug discovery, optimize candidate selection, and enhance drugsafety assessments.

•Oct 30, 2023•0 citations
Quantum computing has become increasingly visible in pharmaceutical research, yet the evidentiary meaning of an “advantage” claim remains unsettled. Drug discovery contains heterogeneous scientific decisions, data structures, computational abstractions, validation standards, and translational consequences. Consequently, improvement in circuit execution, molecular-energy estimation, sampling, classification, or candidate generation cannot by itself establish pharmaceutical usefulness. This Origin
The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.
Quantum computing promises to be a game changer for drug discovery and battery development as it will enable simulations of complex molecular and material systems not possible in classical regimes. Here, we introduce a hardware-aware, hybrid quantum-classical framework designed for practical pharmaceutical and energy problems. Extending state-of-the-art results from quantum machine learning, quantum-inspired optimization, and domain-specific datasets, the model improves both scalability and accuracy as well as interpretability. The proposed method is validated from real-drug and battery chemistry with advantages over the traditional method. This interdisciplinary breakthrough tackles major drawbacks of current quantum approaches and provides a realistic pathway towards industrial implementation in chemistry-led innovation.
The evolution of molecular formulations into medications to treat or remedy diseases is the foundation of the pharmaceutical business. Therefore, it is crucial that the pharmaceutical industry devotes a full 15% of its sales to research and development, which accounts for more than 20% of all R&D expenditures across all productions in the global economy. The trial-and-error method is typically used to create drugs, which is not only expensive but also risky and difficult to complete. Drug companies may potentially save a huge money and time by using quantum computing to better understand drugs and their effects on people. By enabling businesses to undertake more drug discoveries and develop breakthrough medical treatments, these computer advancements have the potential to significantly boost efficiency and lead to a more productive pharmaceutical industry. Pharmaceutical research and development has recently embraced artificial intelligence (AI). The succeeding digital frontier in drug detection is quantum computing (QC).
In the field of pharmaceutical science, there is an increasing demand for advanced computational techniques to enhance drug discovery and understand complex molecular interactions. Classical models, despite their strengths, often struggle with complex biological systems and accurate drug predictions. Quantum computing, using qubits that exist in multiple states, processes information at unparalleled speeds. This chapter sheds light on the principles of quantum computing, emphasizing algorithms specifically designed for pharmaceutical applications. These methods signal groundbreaking advancements in drug design, molecular simulation, and drug interaction predictions. Quantum computers have the potential to surpass classical computers in simulating intricate molecules, thus offering more precise drug side effect forecasts. While challenges such as noise and error rates remain, the continuous evolution of quantum technology holds significant potential for breakthroughs in drug discovery and development.
The pharmaceutical industry stands at the forefront of scientific innovation, aiming to develop novel drugs that address the world's most pressing health challenges. However, the process of drug discovery and development is wrought withchallenges, including the need for precision in molecular modelling, the efficientselection of promising drug candidates, and the rigorous evaluation of safety profiles. In response to these challenges, this research project explores the fusion ofquantum computing and machine learning to revolutionize pharmaceutical dataanalysis. Quantum computing offers an unprecedented opportunity to simulatemolecular structures and properties with unparalleled accuracy. In tandem withquantum machine learning algorithms, this research harnesses the power of quantum computational supremacy to unlock hidden insights within pharmaceuticaldatasets. By leveraging the capabilities of quantum computing for molecular simulation and the data analysis prowess of quantum machine learning, this studyseeks to expedite drug discovery, optimize candidate selection, and enhance drugsafety assessments.